Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
Diabetes Care. 2010 May;33(5):964-8. doi: 10.2337/dc09-1810. Epub 2010 Feb 11.
Gestational diabetes mellitus (GDM) may cause obesity in the offspring. The objective was to assess the effect of treatment for mild GDM on the BMI of 4- to 5-year-old children.
Participants were 199 mothers who participated in a randomized controlled trial of the treatment of mild GDM during pregnancy and their children. Trained nurses measured the height and weight of the children at preschool visits in a state-wide surveillance program in the state of South Australia. The main outcome measure was age- and sex-specific BMI Z score based on standards of the International Obesity Task Force.
At birth, prevalence of macrosomia (birth weight >or=4,000 g) was 5.3% among the 94 children whose mothers were in the intervention group, and 21.9% among the 105 children in the routine care control group. At 4- to 5-years-old, mean (SD) BMI Z score was 0.49 (1.20) in intervention children and 0.41 (1.40) among controls. The difference between treatment groups was 0.08 (95% CI -0.29 to 0.44), an estimate minimally changed by adjustment for maternal race, parity, age, and socio-economic index (0.08 [-0.29 to 0.45]). Evaluating BMI >or=85th percentile rather than continuous BMI Z score gave similarly null results.
Although treatment of GDM substantially reduced macrosomia at birth, it did not result in a change in BMI at age 4- to 5-years-old.
妊娠期糖尿病(GDM)可能导致后代肥胖。本研究旨在评估治疗轻度 GDM 对 4-5 岁儿童 BMI 的影响。
参与者为 199 名患有轻度 GDM 的孕妇及其子女。在南澳大利亚州全州监测计划中,经过培训的护士在儿童入读幼儿园时测量其身高和体重。主要观察指标为基于国际肥胖工作组标准的年龄和性别特异性 BMI Z 评分。
在出生时,干预组 94 名儿童中巨大儿(出生体重≥4000 克)的患病率为 5.3%,而常规护理对照组 105 名儿童中为 21.9%。在 4-5 岁时,干预组儿童的平均(SD)BMI Z 评分为 0.49(1.20),对照组为 0.41(1.40)。两组之间的差异为 0.08(95%CI-0.29 至 0.44),经过对母亲种族、产次、年龄和社会经济指数的调整,估计值变化极小(0.08[-0.29 至 0.45])。评估 BMI≥85 百分位而不是连续 BMI Z 评分也得到了类似的阴性结果。
尽管治疗 GDM 可显著降低出生时的巨大儿发生率,但并未导致 4-5 岁时 BMI 发生变化。